The executive team at EpimAb Biotherapeutics has experience in the therapeutic and financial industries. They have worked as analysts and a vice president at various companies, including Passaic Capital, Thirty30 Capital, Jefferies & Company, and Wells Fargo Securities. They hold degrees in pharmaceutical sciences and biochemistry from the University of Michigan and the University of Illinois Urbana-Champaign, respectively.
View all